Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee. - Suppr | 超能文献

Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.

出版信息

AIDS. 1998 Jul 30;12(11):1259-65.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.

AIDS. 1998 Jul 30;12(11):1259-65.

2

Long-term prognosis following zidovudine monotherapy in primary human immunodeficiency virus type 1 infection.齐多夫定单药治疗原发性1型人类免疫缺陷病毒感染后的长期预后。

J Infect Dis. 1999 Jun;179(6):1549-52. doi: 10.1086/314777.

3

Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.接受司他夫定与齐多夫定治疗的HIV感染患者的疾病进展情况。

J Clin Epidemiol. 2004 Jan;57(1):89-97. doi: 10.1016/S0895-4356(03)00245-2.

4

[The issue of inhibitors of retroviral infections].[逆转录病毒感染的抑制剂问题]

Voen Med Zh. 2003;324(4):53-5.

5

Amprenavir study results released.

AIDS Patient Care STDS. 1999 Dec;13(12):754.

6

A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.在感染HIV的儿童中，于当前核苷类逆转录酶抑制剂治疗基础上加用拉米夫定或匹配安慰剂的随机双盲试验：PENTA-4试验。欧洲儿科艾滋病治疗网络

AIDS. 1998 Oct 1;12(14):F151-60.

7

Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.安普那韦联合拉米夫定和齐多夫定与拉米夫定和齐多夫定单药治疗初治的HIV-1感染成人的疗效比较。安普那韦PROAB3001国际研究团队。

Antivir Ther. 2000 Sep;5(3):215-25.

8

Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment.

Stat Med. 2004 Feb 28;23(4):571-90. doi: 10.1002/sim.1618.

9

South Africa: setting the wrong example.

Nat Med. 1999 Jan;5(1):1. doi: 10.1038/4666.

10

The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.与去羟肌苷相比，齐多夫定对晚期HIV感染者健康状况及功能的影响，以及既往接受齐多夫定治疗的不同疗程。艾滋病临床试验组116/117研究小组。

Antivir Ther. 1996 Jan;1(1):21-32.

引用本文的文献

1

When to start antiretroviral treatment? A history and analysis of a scientific controversy.何时开始抗逆转录病毒治疗？一场科学争论的历史与分析。

South Afr J HIV Med. 2017 Dec 5;18(1):734. doi: 10.4102/sajhivmed.v18i1.734. eCollection 2017.

2

When to start antiretroviral therapy.何时开始抗逆转录病毒治疗。

Curr Infect Dis Rep. 2011 Feb;13(1):60-7. doi: 10.1007/s11908-010-0154-8.

3

Clinical trials of antiretroviral drugs: the role of the MRC AIDS Therapeutic Trials Committee (ATTC) and the MRC Clinical Trials Unit (CTU).抗逆转录病毒药物的临床试验：医学研究委员会艾滋病治疗试验委员会（ATTC）和医学研究委员会临床试验单位（CTU）的作用。

Br J Clin Pharmacol. 2003 May;55(5):469-72. doi: 10.1046/j.1365-2125.2003.01842.x.